SCHEMBL2326010

SCHEMBL2326010

CCc1ccc2ccc(S(=O)(=O)Cl)cc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
CYP2A6 P11509 1/20 0.50
CA2 P00918 1/20 0.44
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
MMP2 P08253 1/20 0.38
MMP13 P45452 1/20 0.38
AKR1C3 P42330 1/20 0.38
AKR1C2 P52895 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 2/20 0.37
NPC1 O15118 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TSHR P16473 2/20 0.37
UCHL1 P09936 1/20 0.37
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2263247 0.82 LMNA (0.46) CA2L3MBTL1ALDH1A1LMNAMAPK1
SCHEMBL30615201 0.82 LMNA (0.46) CA2L3MBTL1ALDH1A1LMNAMAPK1
SCHEMBL7419485 0.82 CYP1A2 (0.50) CYP1A2CYP2A6CA2KMT2AMEN1
SCHEMBL28491541 0.82 CYP1A2 (0.50) CYP1A2CYP2A6CA2KMT2AMEN1
SCHEMBL344067 0.78 CA2 (0.61) CA2KMT2AL3MBTL1ALDH1A1LMNA
SCHEMBL11150222 0.78 CYP1A2 (0.46) CYP1A2CYP2A6CA2KMT2AMEN1
SCHEMBL2329828 0.78 CYP1A2 (0.46) CYP1A2CYP2A6CA2KMT2AMEN1
SCHEMBL1878783 0.78 CYP2A6 (0.76) CYP1A2CYP2A6KMT2AMEN1AKR1C3
SCHEMBL29475635 0.78 CYP2A6 (0.76) CYP1A2CYP2A6KMT2AMEN1AKR1C3
SCHEMBL2633044 0.78 CYP1A2 (0.53) CYP1A2CYP2A6CA2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0853618-B1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL -AZAHETEROCYCLYLAMIDE COMPOUNDS AVENTIS PHARMA INC (US) 2011-08-17 EP disclosed
EP-0853618-A4 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHONE POULENC RORER PHARMA (US) 2000-03-15 EP disclosed
US-5958918-A Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N- (aminominomethyl)phenylalkyl!-azaheterocyclylamide compounds RHONE-POULENC RORER PHARMACEUTICALS INC. 1999-09-28 US disclosed
CN-1190395-A Substituted (sulfonic, sulfinic, sulfonamido or sulfonamido) N- [ aminoiminomethyl) phenylalkyl ] -azaheterocyclic amide compounds RHONE POULENC RORER PHARMA (US) 1998-08-12 CN disclosed
EP-0853618-A1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1998-07-22 EP disclosed
WO-1996040679-A1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N-[(AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-12-19 WO disclosed